Facebook
Twitter
LinkedIn
Google+
ForwardRecent Courses
| Title | Credit |
Start and expiration dates |
Member price | Non-member price |
|---|---|---|---|---|
| 2017 Pediatric Rx, Module 4- GI Drugs |
|
10/01/2017 to 09/30/2019 | $5.00 | $10.00 |
| 2017 Pediatric RX, Module 5: Nutraceutical and Supplement Use in Children |
|
10/01/2017 to 09/30/2019 | $10.00 | $20.00 |
| 2017 Pediatric RX, Module 1: What's New in Pediatric Pharmacology |
|
10/01/2017 to 09/30/2019 | $12.00 | $25.00 |
| 2017 Pediatric Rx, Module 2- Respiratory Drugs |
|
10/01/2017 to 09/30/2019 | $12.00 | $25.00 |
| 2017 Pediatric Pharmacology Bundle SAVE | 10/01/2017 to 09/30/2019 | $30.00 | $75.00 |
Pages
Pending Activities
Transcript
More NAPNAP CE Courses!
PedsCESM News:
Tackling Atopic Dermatitis: Five Things the Pediatric Care Team Should Know - Medscape Education and NAPNAP
This free activity is offered by Medscape and NAPNAP to inform pediatricians, primary care physicians, dermatologists, pediatric nurse practitioners, and physician assistants about the pathophysiology and characteristics of, and treatment options for, mild, moderate, and severe atopic dermatitis (AD) and how to facilitate shared decision making to improve patient adherence and outcomes. (Approved for 0.50 AMA PRA Category 1 credits(s)TM 0.50 ABIM MOC points, 0.50 NAPNAP Contact Hours(s) of which 0.25 contain pharmacology content). This activity is supported by an educational grant from Pfizer Inc. (Expires March 27, 2019)
Clinical Insights in Pediatrics: Type 2 Diabetes in Children and Adolescents with Obesity: Screening, Diagnosis and Management - cmecorner.com
This activity offered by cmecorner.com will address T2DM in pediatric patients which is rapidly progressing. The American Diabetes Association has developed criteria for screening diagnosis, and management considerations for T2DM in children and adolescents. (Approved for 0.75 NAPNAP contact hours, of which contain 0.25 pharmacology content) CME: 0.75 AMA PRA Category 1 CreditTM . (Expires April 30, 2019)
Clinical Insights in Pediatrics: Juvenile Idiopathic Arthritis: Diagnosis and Management in Primary Care - cmecorner.com
This activity offered by cmecorner.com discusses the most common inflammatory arthritis in the pediatric population. Over 300,000 children and adolescents are affected by JIA in the USA.The management of JIA represents a significant challenge to physicians, NPs, and other clinicians, particularly those in front-line specialties such as pediatrics and primary care. This activity will address timely diagnosis/classification of JIA and appropriate treatment, which are critical for preventing joint damage and improving long-term outcomes. Approved for 0.75 NAPNAP Contact Hour of which 0.25 contain pharmacology content. (Expires September 14, 2019).